5hdw
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='5hdw' size='340' side='right'caption='[[5hdw]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='5hdw' size='340' side='right'caption='[[5hdw]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5hdw]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5hdw]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HDW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5HDW FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5hdw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5hdw OCA], [https://pdbe.org/5hdw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5hdw RCSB], [https://www.ebi.ac.uk/pdbsum/5hdw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5hdw ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/FBX3_HUMAN FBX3_HUMAN] Substrate recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Mediates the ubiquitination of HIPK2 and probably that of EP300, leading to rapid degradation by the proteasome. In the presence of PML, HIPK2 ubiquitination still occurs, but degradation is prevented. PML, HIPK2 and FBXO3 may act synergically to activate p53/TP53-dependent transactivation.<ref>PMID:18809579</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 22: | Line 22: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Chen | + | [[Category: Chen BB]] |
- | [[Category: Gronenborn | + | [[Category: Gronenborn AM]] |
- | [[Category: Krzysiak | + | [[Category: Krzysiak TC]] |
- | [[Category: Mallampalli | + | [[Category: Mallampalli RK]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
ApaG Domain of FBxo3
|